You have been watching it for a few weeks now, and you cannot quite put your finger on it. Your 10-year-old used to beg to have friends over. Now he spends every weekend in his room with the door closed. Your daughter has been snapping at everyone in the house for three months. When you try to talk to her, she says she is fine. You know that she is not.
If you hear talk of suicide or self-harm, do not wait
If your child mentions suicide, self-harm, or wanting to disappear, even once, even casually, do not wait for the next available appointment. Call your pediatrician today. Call or text the 988 Suicide & Crisis Lifeline for free, confidential support 24/7. If you believe your child is in immediate danger, go to the nearest emergency department or call 911.
Maybe it is smaller than that. A kid who used to love soccer suddenly has a reason every week why she cannot go to practice. The pasta she always asked for is now “gross.” She is in bed by 7:30 some nights and up at 3 a.m. on others. She cries about things you cannot trace back to anything.
You find yourself standing in the kitchen wondering: is this just what growing up looks like, or is something else going on? That question deserves a real answer.
Depression in kids is more common than most parents think. CDC parent-reported surveillance found that about 4.4 percent of U.S. children ages 3 to 17 carry a depression diagnosis.1 SAMHSA’s most recent National Survey on Drug Use and Health found that roughly one in five adolescents ages 12 to 17 (about 19.5 percent) lived through a major depressive episode in the past year, and close to three-quarters of those teens had episodes severe enough to interfere with daily life.1 That is several kids in any classroom, and most of them are not the kids you would expect.
Here is what the evidence says about the line between sadness and depression, what to watch for, and when to bring it to someone.
01. When sadness becomes something more
Every child experiences sadness. Disappointment, loss, frustration, loneliness: these are part of growing up, and the capacity to feel them is healthy, not a problem to solve.
What separates a normal emotional response from clinical depression comes down to three things: duration, pervasiveness, and functional impairment.
Normal sadness is typically tied to a specific event, proportionate to what happened, and it resolves. A child who is sad for a week after a close friend moves away, then gradually returns to their usual self, is responding to something real. That is not depression.
Clinical depression, by contrast, persists. The DSM-5 (the diagnostic manual psychiatrists use) requires five or more symptoms present for at least two weeks, nearly every day, with at least one of those symptoms being depressed mood or anhedonia, the clinical term for a loss of interest and pleasure in activities the child used to enjoy.2 Those symptoms must cause real problems with how the child functions at school, at home, or with friends.2 The American Academy of Child and Adolescent Psychiatry adds that the trouble should show up in more than one part of life, not just at home and not only around one specific stressor.5
The practical translation
That two-week threshold and the pervasiveness requirement are not arbitrary. They exist to distinguish clinical depression from grief, from a hard week, from the normal fluctuations of mood that come with being human. When the symptoms outlast the trigger, span multiple areas of your child’s life, and are causing measurable problems with how they function, that is when professional evaluation makes sense.
02. The sign most parents miss: it often looks like anger, not sadness
Here is the piece that surprises nearly every parent I work with. In children and adolescents, the primary mood symptom of depression is frequently not sadness. It is irritability.
This is not a clinical quirk or a rare exception. The DSM-5 explicitly states that in children and teens, irritable mood may substitute for depressed mood as the cardinal symptom of major depressive disorder.2 The AAP-endorsed GLAD-PC guidelines for primary care management of adolescent depression use this same framing.3 And the developmental research on mood in young people consistently shows that the depressed child is often the angry child, the snapping child, the one who is set off by small things and cannot quite explain why.4
Why does this matter? Because irritability in kids is easy to misread. It looks like defiance. It looks like a bad attitude. It looks like the child being difficult, particularly during the teenage years when friction with parents is developmentally expected. Parents spend months trying to address the behavior, not realizing the behavior is a symptom.
The distinguishing features are the same ones that separate normal sadness from clinical depression: duration, breadth, and impairment. Developmentally normal adolescent irritability is episodic, tied to specific frustrations, and doesn’t substantially alter the way the teenager moves through their life. The irritability of depression is chronic, non-episodic, present across settings, and accompanied by other depressive symptoms: fatigue, sleep changes, loss of interest, withdrawal, trouble concentrating.4
If your child has been persistently irritable for weeks, and that irritability is accompanied by any of the other symptoms described in this post, it is worth raising with your pediatrician. This is not bad parenting or a behavioral problem. It may be a mood disorder.
03. Other signs that go beyond ordinary moodiness
Depression is a whole-body condition. It shows up in ways that are easy to attribute to other things. Beyond persistent sadness or irritability, here are the signs I look for most often:
- Has she lost interest in the activities she used to love? The soccer player who is “tired” every Saturday. The kid who used to live for art class and now will not pick up a pencil.
- Has her sleep changed? Sleeping all the time, or up at 3 a.m. and exhausted by lunch.
- Has her appetite changed? Eating much more, much less, or noticeable weight changes.
- Is she tired in a way that does not match what she did today?
- Is she having trouble concentrating? This often gets mistaken for ADHD.
- Is she showing up at the pediatrician with stomachaches or headaches that never get a clear explanation?
- Has she pulled away from friends and family?
- In older kids, are you hearing language about feeling hopeless, worthless, or like a burden?
The AACAP practice parameter for pediatric depression emphasizes that these symptoms should be evaluated across school, home, and social settings.5 A kid who is rough only at home with you might be reacting to something at home. A kid who is rough at home, at school, and with friends all at once is telling you something bigger.
04. How common is this, and who is screening for it?
Depression in adolescents is common enough that the major medical organizations have built systematic screening into routine care.
The U.S. Preventive Services Task Force, the federal panel that sets evidence-based screening recommendations for primary care, reaffirmed in 2022 a Grade B recommendation for screening all adolescents ages 12 to 18 for major depression, as long as the practice has systems in place to follow up on positive screens.6 (A Grade B recommendation means there is moderate evidence of net benefit, and your insurance has to cover the screen.) The AAP-endorsed GLAD-PC guidelines go further: screen at every well-child visit starting at age 12, using a validated tool, and have a clear plan for what happens when a screen comes back positive.3
The most common screening tool is the PHQ-A, a nine-question adolescent version of the Patient Health Questionnaire. It maps directly onto the DSM-5 depression criteria and takes about five minutes to fill out. At a score of 10 or higher, validated against structured psychiatric interviews in adolescents, the PHQ-A picks up roughly 89 percent of true depression cases (sensitivity) while correctly clearing about 77 percent of teens who are not depressed (specificity).7 Those are good numbers for a five-minute questionnaire. It is what I use in my practice.
If your teenager’s pediatrician has not discussed mood at the last visit, you can bring it up. “I would like a depression screen at the next visit” is enough. The conversation usually starts with that questionnaire, and that questionnaire can catch something that has been quietly affecting your kid for months.
05. What the research says about treatment
The treatment evidence for pediatric depression is strong, and it is reassuring.
For mild-to-moderate depression, the AACAP practice parameter recommends starting with active support, education, and psychotherapy, particularly cognitive behavioral therapy (CBT, a structured talk therapy that helps kids notice and shift unhelpful thought patterns).5 Medication is not the first move when symptoms are mild.
For moderate-to-severe depression, the landmark study is TADS, the Treatment for Adolescents with Depression Study. Researchers randomized 439 teens ages 12 to 17 to one of four groups: fluoxetine (Prozac) alone, CBT alone, combination therapy (both), or placebo. Response rates at 12 weeks were:8
- Combination therapy: 71 percent
- Fluoxetine alone: 61 percent
- CBT alone: 43 percent
- Placebo: 35 percent
Combination therapy beat every other arm. Longer-term TADS follow-up also suggested that adding CBT helped buffer some of the suicidality risk that fluoxetine can carry on its own.8 Fluoxetine is the only antidepressant FDA-approved for kids as young as 8, and both an AHRQ systematic review and a Cochrane network meta-analysis (two of the most rigorous types of evidence reviews) confirm fluoxetine as the most consistently supported medication for pediatric depression, with combination therapy outperforming either treatment alone.1011
When a kid does not respond to a first SSRI, the TORDIA trial established the next move: switching to a different medication, but with CBT added on, produced a response rate of about 55 percent, compared to 40 percent for a medication switch alone.9 Therapy plus a different medication beats a medication change in isolation.
In my own practice, when medication becomes part of the plan, the goal is not a forever prescription. The goal is to lift the symptoms enough that therapy can actually do its work, so your kid can build the skills that carry them forward. The medication is the bridge. The therapy is what lasts.
That is the goal. For many kids the bridge is a few months. For others, depression is something they manage longer-term, and staying on medication is part of how they stay well. Either path is a real path. The right length is whatever keeps your kid healthy.
06. When to seek help
You do not need to wait until your child is in crisis to bring this up with your pediatrician. The AAP-endorsed GLAD-PC guidelines and the AACAP practice parameter both frame early identification and proactive management as the standard of care, started before the depression has shaped a kid’s whole school year or friend group.35 If any of the following is true, it is time to make the call:
- Persistent sadness, emptiness, or irritability that has lasted most of the day, most days, for two or more weeks.
- Your child has lost interest in activities they used to love, or has pulled away from friends and family.
- You are noticing real changes in sleep, appetite, energy, or focus.
- School performance has slipped, or your child has started missing school.
- Your child has said anything, even offhand, about feeling hopeless, worthless, or like things would be better if they were not around. Take these seriously every single time.
- You have a parent-gut sense that something is different, even if you cannot name it.
Getting a depression evaluated early is not overreacting to a rough patch. It is investing in a trajectory. A validated screening tool, an honest conversation with your pediatrician, and a clear follow-up plan are the starting point.
What you are doing right now, paying attention, taking your child’s mood seriously, is the first and most important step. Most kids with depression do well when they get the right support at the right time. The hard part is recognizing that the irritability, the withdrawal, the “I’m fine” that does not match what you are seeing, might be depression, not defiance.
Wondering if it’s time to talk to someone?
If you are in California, the team at Resonate Pediatrics is here for exactly that. We evaluate and treat children and teens ages 5 to 18.
Book an evaluationSources
- Bitsko RH, Claussen AH, Lichstein J, et al. Mental health surveillance among children: United States, 2013–2019. MMWR Suppl. 2022;71(2):1-42. pubmed.ncbi.nlm.nih.gov/35202358/. Substance Abuse and Mental Health Services Administration. Key Substance Use and Mental Health Indicators in the United States: Results from the 2022 National Survey on Drug Use and Health. HHS Publication No. PEP23-07-01-006. Rockville, MD: SAMHSA; 2023.
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). Washington, DC: American Psychiatric Association Publishing; 2022. doi.org/10.1176/appi.books.9780890425787.
- Zuckerbrot RA, Cheung A, Jensen PS, Stein REK, Laraque D; GLAD-PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part I. Practice preparation, identification, assessment, and initial management. Pediatrics. 2018;141(3):e20174081. pubmed.ncbi.nlm.nih.gov/29483200/. Cheung AH, Zuckerbrot RA, Jensen PS, Laraque D, Stein REK; GLAD-PC Steering Group. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): Part II. Treatment and ongoing management. Pediatrics. 2018;141(3):e20174082. pubmed.ncbi.nlm.nih.gov/29483201/.
- Leibenluft E, Stoddard J. The developmental psychopathology of irritability. Dev Psychopathol. 2013;25(4 Pt 2):1473-1487. pubmed.ncbi.nlm.nih.gov/24342843/.
- Walter HJ, Abright AR, Bukstein OG, et al. Clinical practice guideline for the assessment and treatment of children and adolescents with major and persistent depressive disorders. J Am Acad Child Adolesc Psychiatry. 2023;62(5):479-502. pubmed.ncbi.nlm.nih.gov/36273673/. (Updates and replaces the AACAP 2007 practice parameter.)
- Mangione CM, Barry MJ, Nicholson WK, et al; US Preventive Services Task Force. Screening for depression and suicide risk in children and adolescents: US Preventive Services Task Force recommendation statement. JAMA. 2022;328(15):1534-1542. pubmed.ncbi.nlm.nih.gov/36219410/.
- Richardson LP, Rockhill C, Russo JE, et al. Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents. Pediatrics. 2010;126(6):1117-1123. pubmed.ncbi.nlm.nih.gov/21041282/.
- March J, Silva S, Petrycki S, et al; Treatment for Adolescents With Depression Study (TADS) Team. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. 2004;292(7):807-820. pubmed.ncbi.nlm.nih.gov/15315995/.
- Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA. 2008;299(8):901-913. pubmed.ncbi.nlm.nih.gov/18314433/.
- Viswanathan M, Kennedy SM, McKeeman J, et al. Treatment of depression in children and adolescents: a systematic review. JAMA Pediatr. 2022;176(4):e216357. pubmed.ncbi.nlm.nih.gov/35040905/.
- Hetrick SE, McKenzie JE, Bailey AP, et al. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021;5:CD013674. pubmed.ncbi.nlm.nih.gov/34029378/.